TERT-572 Completed Phase 2 Trials for Metastatic Non-Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01935154Efficacy Study of Vx001 Vaccine in NSCLC Patients